Journal of Diagnostics Concepts & Practice ›› 2024, Vol. 23 ›› Issue (04): 439-444.doi: 10.16150/j.1671-2870.2024.04.013
• Review article • Previous Articles Next Articles
LI Zhuohan1,2, HUANG Xinyun2, GUO Rui2, LI Biao2()
Received:
2023-07-19
Accepted:
2023-10-12
Online:
2024-08-25
Published:
2024-08-25
Contact:
LI Biao
E-mail:lb10363@rjh.com.cn
CLC Number:
LI Zhuohan, HUANG Xinyun, GUO Rui, LI Biao. 18F-FDG PET/CT in the diagnosis and prognosis evaluation of follicular lymphoma[J]. Journal of Diagnostics Concepts & Practice, 2024, 23(04): 439-444.
Table 1
Predictive ability of PET/CT parameters for PFS in FL patients in different studies
作者 | 患者人数(例) | FL患者类型 | 纳入PET/CT的参数 | 中位数 | 截断值 | 对PFS的差异(P值) |
---|---|---|---|---|---|---|
Kuroki W, et al[ | 45 | 高肿瘤负荷FL | TMTV | 220 | 501.4 | 0.005 |
TLG | 1 173.3 | 3 284.1 | <0.001 | |||
SUVmax | 13.27 | 14.25 | 0.060 | |||
Liang J H, et al[ | 48 | FL | TMTV | 114.3 | 476.4 | 0.002 |
TLG | 594.4 | 2 676.9 | <0.001 | |||
Zhou Y, et al.[ | 84 | FL | TMTV | / | 179.84 | 0.005 |
TLG | / | 1 364.60 | 0.000 1 | |||
SUVmax | / | 10.44 | 0.043 | |||
Li H, et al.[ | 126 | 1-3a级FL | TMTV | / | 408.72 | <0.001 |
TLG | / | 1 446.98 | <0.001 | |||
SUVmax | / | 17.60 | 0.001 | |||
Dmax | / | 56.73 | <0.001 | |||
Meignan M, et al[ | 184 | 多中心高肿瘤负荷或晚期FL | TMTV | 297 | 510 | 0.002 |
[1] | Cerhan J R. Epidemiology of Follicular Lymphoma[J]. Hematol Oncol Clin North Am, 2020, 34(4):631-646. |
[2] | ZHA J, FAN L, YI S, et al. Clinical features and outcomes of 1845 patients with follicular lymphoma: a real-world multicenter experience in China[J]. J Hematol Oncol, 2021, 14(1):131. |
[3] | LI H, WANG M, ZHANG Y, et al. Prediction of prognosis and pathologic grade in follicular lymphoma using 18F-FDG PET/CT[J]. Front Oncol. 2022; 12:943151. |
[4] |
MEIGNAN M, COTTEREAU A S, VERSARI A, et al. Baseline metabolic tumor volume predicts outcome in high-tumor-burden follicular lymphoma: A pooled analysis of three multicenter studies[J]. J Clin Oncol, 2016, 34(30):3618-3626.
doi: 10.1200/JCO.2016.66.9440 pmid: 27551111 |
[5] | DÍAZ-SILVÁN A, OTÓN-SÁNCHEZ L F, CARESIA-ARÓZTEGUI A P, et al. Clinical application of [18F]FDG PET/CT in follicular lymphoma[J]. Rev Esp Med Nucl Imagen Mol (Engl Ed), 2022, 41(3):202-212. |
[6] | 张欢, 胡斌, 何柳, 等. 基线18F-FDG PET/CT显像在滤泡性淋巴瘤分布、分级和分期中的价值[J]. 现代肿瘤医学, 2023, 31(13):2496-2501. |
ZHANG H, HU B, HE L, et al. The value of baseline 18F-FDG PET/CT imaging in the distribution,grading and staging of follicular lymphoma[J]. Mod Oncol, 2023, 31: 2496-2501. | |
[7] | 中华医学会核医学分会. 淋巴瘤18F-FDG PET/CT及PET/MR显像临床应用指南(2021版)[J]. 中华核医学与分子影像杂志, 2021, 41(3):161-169. |
Chinese Society of Nuclear Medicine. Clinical practice guideline of 18F-FDG PET/CT and PET/MR in lymphoma (2021 edition)[J]. Chin J Nucl Med Imaging, 2021, 41(3):161-169. | |
[8] | KUROKI W, KITADATE A, ISHIYAMA K, et al. High baseline total lesion glycolysis predicts early progression of disease within 24 months in patients with high-tumor-burden follicular lymphoma[J]. Int J Hematol, 2022, 116(5):712-722. |
[9] | EL-GALALY T C, VILLA D, CHEAH C Y, et al. Pre-treatment total metabolic tumour volumes in lymphoma: Does quantity matter?[J]. Br J Haematol, 2022, 197(2):139-155. |
[10] | 中国抗癌协会淋巴瘤专业委员会, 中华医学会血液学分会. 中国滤泡性淋巴瘤诊断与治疗指南(2020年版)[J]. 中华血液学杂志, 2020, 41(7):537-544. |
Chinese Society of Lymphoma, Chinese Anti-cancer Association; Chinese Society of Hematology, Chinese Medical Association. Chinese guidelines for diagnosis and treatment of follicular lymphoma (2020)[J]. Chin J Hematol, 2020, 41(7):537-544. | |
[11] |
RODIER C, KANAGARATNAM L, MORLAND D, et al. Risk factors of progression in low-tumor burden follicular lymphoma initially managed by watch and wait in the era of PET and rituximab[J]. Hemasphere, 2023, 7(5):e861.
doi: 10.1097/HS9.0000000000000861 pmid: 37125257 |
[12] | LECCISOTTI L, MACCORA D, MALAFRONTE R, et al. Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden[J]. J Cancer Res Clin Oncol, 2023, 149(7):2783-2791. |
[13] | YANG Q, LUO Y, ZHANG Y, et al. Baseline [18F]FDG PET/CT may predict the outcome of newly diagnosed follicular lymphoma in patients managed with initial “watch-and-wait” approach[J]. Eur Radiol, 2022, 32(8):5568-5576. |
[14] | DREVAL K, HILTON L K, CRUZ M, et al. Genetic subdivisions of follicular lymphoma defined by distinct co-ding and noncoding mutation patterns[J]. Blood, 2023, 142(6):561-573. |
[15] | STEUSSY B, LEKOSTAJ J, QIAN Q, et al. Leukemic transdifferentiation of follicular lymphoma into an acute histiocytic leukemia in a 52-year-old caucasian woman[J]. Lab Med, 2016, 47(2):155-157. |
[16] | 林志娟, 查洁, 易树华, 等. 伴弥漫大B细胞成分的初诊滤泡淋巴瘤患者的临床特征及生存[J]. 中华血液学杂志, 2022, 43(6):456-462. |
LIN Z J, ZHA J, YI S H, et al. Clinical features and outcomes of newly diagnosed follicular lymphoma concurrent with diffuse large B-cell lymphoma component[J]. Chin J Hematol, 2022, 43(6):456-462. | |
[17] | SCHÖDER H, NOY A, GÖNEN M, et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma[J]. J Clin Oncol, 2005, 23(21):4643-4651. |
[18] | RAJAMÄKI A, KUITUNEN H, SORIGUE M, et al. FDG-PET/CT-guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma. Cancer Med. 2023; 12(1):407-411. |
[19] |
MIR F, BARRINGTON S F, BROWN H, et al. Baseline SUVmax did not predict histological transformation in follicular lymphoma in the phase 3 GALLIUM study[J]. Blood, 2020, 135(15):1214-1218.
doi: 10.1182/blood.2019001091 pmid: 31961926 |
[20] | LIPPI M, GIANOTTI S, FAMA A, et al. Texture analysis and multiple-instance learning for the classification of malignant lymphomas[J]. Comput Methods Programs Biomed, 2020, 185:105153. |
[21] | DE JESUS F M, YIN Y, MANTZOROU-KYRIAKI E, et al. Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic [18F]FDG PET/CT features[J]. Eur J Nucl Med Mol Imaging, 2022, 49(5):1535-1543. |
[22] | KOÇAK B, DURMAZ E Ş, ATEŞ E, et al. Radiomics with artificial intelligence: a practical guide for beginners[J]. Diagn Interv Radiol, 2019, 25(6):485-495. |
[23] | LIANG J H, ZHANG Y P, XIA J, et al. Prognostic value of baseline and interim total metabolic tumor volume and total lesion glycolysis measured on 18F-FDG PET-CT in patients with follicular lymphoma[J]. Cancer Res Treat, 2019, 51(4):1479-1487. |
[24] | ZHOU Y, ZHAO Z, LI J, et al. Prognostic values of baseline, interim and end-of therapy 18F-FDG PET/CT in patients with follicular lymphoma[J]. Cancer Manag Res, 2019, 11:6871-6885. |
[25] | COTTEREAU A S, NIOCHE C, DIRAND A S, et al. 18F-FDG PET dissemination features in diffuse large b-cell lymphoma are predictive of outcome[J]. J Nucl Med, 2020, 61(1):40-45. |
[26] | EERTINK J J, VAN DE BRUG T, WIEGERS S E, et al. 18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma[J]. Eur J Nucl Med Mol Imaging, 2022, 49(3):932-942. |
[27] |
COTTEREAU A S, MEIGNAN M, NIOCHE C, et al. Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT†[J]. Ann Oncol, 2021, 32(3):404-411.
doi: 10.1016/j.annonc.2020.11.019 pmid: 33278600 |
[28] | ZEMAN M N, AKIN E A, MERRYMAN R W, et al. Interim FDG-PET/CT for response assessment of lymphoma[J]. Semin Nucl Med, 2023, 53(3):371-388. |
[29] | JÓNA Á, KENYERES A, BARNA S, et al. Clinical and biological prognostic factors in follicular lymphoma patients[J]. PLoS One, 2022, 17(8):e0272787. |
[30] | SUN N, QIAO W, XING Y, et al. Prognostic value of interim 18F-FDG PET/CT in adult follicular lymphoma treated with R-CHOP[J]. Ann Hematol, 2023, 102(4):795-800. |
[31] | BOO S H, O J H, KWON S J, et al. Predictive value of interim and end-of-therapy 18F-FDG PET/CT in patients with follicular lymphoma[J]. Nucl Med Mol Imaging, 2019, 53(4):263-269. |
[32] |
TATSUMI M, ISOHASHI K, MATSUNAGA K, et al. Volumetric and texture analysis on FDG PET in evaluating and predicting treatment response and recurrence after chemotherapy in follicular lymphoma[J]. Int J Clin Oncol, 2019, 24(10):1292-1300.
doi: 10.1007/s10147-019-01482-2 pmid: 31165310 |
[33] | DEL PUIG CÓZAR-SANTIAGO M, GARCÍA-GARZÓN J R, MORAGAS-FREIXA M, et al. Optimisation of metabolic criteria in the prognostic assessment in patients with lymphoma. A multicentre study. Optimización de los criterios metabólicos en la valoración pronóstica de los pacientes con linfoma. Estudio multicéntrico[J]. Rev Esp Med Nucl Imagen Mol, 2017, 36(5):304-311. |
[34] |
SIBILLE L, SEIFERT R, AVRAMOVIC N, et al. 18F-FDG PET/CT uptake classification in lymphoma and lung cancer by using deep convolutional neural networks[J]. Radiology, 2020, 294(2):445-452.
doi: 10.1148/radiol.2019191114 pmid: 31821122 |
[35] | BLANC-DURAND P, JÉGOU S, KANOUN S, et al. Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural network[J]. Eur J Nucl Med Mol Imaging, 2021, 48(5):1362-1370. |
[36] | GIRUM K B, REBAUD L, COTTEREAU A S, et al. 18F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients[J]. J Nucl Med, 2022, 63(12):1925-1932. |
[37] | 刘娟, 颜希月, 张亚平, 等. 18F-FDG PET/CT在黏膜相关淋巴组织淋巴瘤中的预测价值[J]. 中国临床研究, 2022, 35 (05): 649-654. |
LIU J, YAN X Y, ZHANG Y P, et al. Predictive value of 18F-FDG PET/CT in mucosa---associated lymphoid tissue lymphoma[J]. Chin J Clin Res, 2022, 35(5): 649-654. | |
[38] | 王龙胜. 肺黏膜相关淋巴组织淋巴瘤的CT诊断——2023年读片窗(3) [J]. 安徽医学, 2023, 44(03): 361-362. |
WANG L S. CT diagnosis of pulmonary mucosal associated lymphoid tissue lymphoma ---2023 reading window (3)[J]. 2023, 44(03): 361-362. |
[1] | LI Jing, SHAN Zhongyan. Current status and challenges of diagnosis and treatment of hyperthyroidism in China [J]. Journal of Diagnostics Concepts & Practice, 2024, 23(04): 347-353. |
[2] | ZHOU Jianqiao, ZHANG Lu, XU Shangyan. Current status and challenges in ultrasound diagnosis and treatment of thyroid nodules in China [J]. Journal of Diagnostics Concepts & Practice, 2024, 23(04): 362-370. |
[3] | ZHANG Tianyi, YAN Fuhua. Advances in the diagnosis of abdominal disease based on virtual monoenergetic imaging and iodine map of spectral CT [J]. Journal of Diagnostics Concepts & Practice, 2024, 23(04): 452-456. |
[4] | ZHU Weiwei, LI Qian, WU Fan, ZHAI Zhimin. Gene mutations and their relationship with clinical features in 100 patients with myelodysplastic syndrome [J]. Journal of Diagnostics Concepts & Practice, 2024, 23(03): 305-312. |
[5] | DING Ning, LIU Lin, JIN Peipei, WANG Fang, WANG Tiankai. Diagnostic efficacy analysis of mean reticulated hemoglobin content for diagnosing iron deficiency anemia and its severity [J]. Journal of Diagnostics Concepts & Practice, 2024, 23(03): 318-323. |
[6] | MDS Professional Committee of Hematology Branch of Chinese Geriatrics Society. The consensus on the diagnosis and treatment of elderly myelodysplastic neoplasm in China (2024) [J]. Journal of Diagnostics Concepts & Practice, 2024, 23(03): 285-296. |
[7] | WANG Gang, QI Jinlei, LIU Xinya, REN Rujing, LIN Shaohui, HU Yisong, LI Haixia, XIE Xinyi, WANG Jintao, LI Jianping, ZHU Yikang, GAO Mengyi, YANG Junjie, WANG Yiran, JING Yurong, GENG Jieli, ZHI Nan, CAO Wenwei, XU Qun, YU Xiaoping, ZHU Yuan, ZHOU Ying, WANG Lin, GAO Chao, LI Binyin, CHEN Shengdi, YUAN Fang, DOU Ronghua, LIU Xiaoyun, LI Xuena, YIN Yafu, CHANG Yan, XU Gang, XIN Jiawei, ZHONG Yanting, LI Chunbo, WANG Ying, ZHOU Maigeng, CHEN Xiaochun, representing the China Alzheimer's Disease Report Writing Group . China Alzheimer Report 2024 [J]. Journal of Diagnostics Concepts & Practice, 2024, 23(03): 219-256. |
[8] | GAO Meng, CHAI Weimin, YAN Fuhua. Advance in study on diagnosis of pancreatic cystic tumors on CT/MRI imaging [J]. Journal of Diagnostics Concepts & Practice, 2024, 23(02): 184-191. |
[9] | HUANG Rui, RAO Huiying. Current status, screening and diagnostic strategies for hepatitis C virus infection in the context of “elimination” [J]. Journal of Diagnostics Concepts & Practice, 2024, 23(01): 1-8. |
[10] | HUA Wen, SHEN Huahao. Diagnosis and treatment practice of chest tightness variant asthma in China [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(06): 513-519. |
[11] | NI Zhongxin, CHEN Hui. Study on the diagnostic efficacy of ADNEX model in differentiating metastatic and primary ovarian cancer [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(06): 573-578. |
[12] | WANG Shukui, GU Xinliang. Advances in the study of tsRNA as diagnostic and prognostic biomarkers in cancer [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(05): 413-420. |
[13] | DAI Jingyi, JIANG Jingting. Advances in tumour markers for diagnosis of hepatocellular carcinoma [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(05): 486-493. |
[14] | LIU Yifei. DNA methylation detection assists early screening and diagnosis of tumors [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(04): 393-401. |
[15] | LIU Yingting, YI Hongmei, WANG Xue, YANG Chunxue, OUYANG Binshen XU Haimin, WANG Chaofu. Clinicopathological features and prognosis of 17 cases of duodenal-type follicular lymphoma [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(04): 362-368. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||